Literature DB >> 22895216

Cell distribution differences of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in patients with Kawasaki disease.

Seigo Korematsu1, Yoko Ohta, Naotaka Tamai, Masahiro Takeguchi, Chika Goto, Hiroaki Miyahara, Tatsuya Kawano, Tatsuro Izumi.   

Abstract

The interaction of matrix metalloproteinase (MMP)-9 and tissue inhibitor of matrix metalloproteinase-1 has been implicated in the formation of coronary aneurysms in Kawasaki disease. MMP-9 and tissue inhibitor of matrix metalloproteinase-1 were distributed predominantly in the granulocytes and platelets, respectively, in patients with Kawasaki disease. The plasma values of MMP-9 correlated positively with the circulating neutrophil count. Inhibiting the activity of granulocytes and maintaining the platelet activity might prevent coronary aneurysms.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22895216     DOI： 10.1097/INF.0b013e31825ba6b3

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  10 in total

Review 1.  Metalloproteinases and their natural inhibitors in inflammation and immunity.

Authors:  Rama Khokha; Aditya Murthy; Ashley Weiss
Journal:  Nat Rev Immunol       Date:  2013-09       Impact factor: 53.106

2.  In silico Identification of 10 Hub Genes and an miRNA-mRNA Regulatory Network in Acute Kawasaki Disease.

Authors:  Jin Ma; Huan Gui; Yunjia Tang; Yueyue Ding; Guanghui Qian; Mengjie Yang; Mei Wang; Xiudao Song; Haitao Lv
Journal:  Front Genet       Date:  2021-03-25       Impact factor: 4.599

3.  Adverse drug reaction prediction using scores produced by large-scale drug-protein target docking on high-performance computing machines.

Authors:  Montiago X LaBute; Xiaohua Zhang; Jason Lenderman; Brian J Bennion; Sergio E Wong; Felice C Lightstone
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

4.  GM-CSF primes cardiac inflammation in a mouse model of Kawasaki disease.

Authors:  Angus T Stock; Jacinta A Hansen; Matthew A Sleeman; Brent S McKenzie; Ian P Wicks
Journal:  J Exp Med       Date:  2016-09-05       Impact factor: 14.307

Review 5.  Kawasaki disease: pathophysiology and insights from mouse models.

Authors:  Magali Noval Rivas; Moshe Arditi
Journal:  Nat Rev Rheumatol       Date:  2020-05-26       Impact factor: 20.543

6.  KDmarkers: A biomarker database for investigating epigenetic methylation and gene expression levels in Kawasaki disease.

Authors:  Wei-Sheng Wu; Tzu-Hsien Yang; Kuang-Den Chen; Po-Heng Lin; Guan-Ru Chen; Ho-Chang Kuo
Journal:  Comput Struct Biotechnol J       Date:  2022-03-10       Impact factor: 7.271

7.  Correlation Between Matrix Metalloproteinases With Coronary Artery Lesion Caused by Kawasaki Disease.

Authors:  Fang Tian; Linxi Ma; Renbing Zhao; Lijuan Ji; Xiufen Wang; Wenli Sun; Yu Jiang
Journal:  Front Pediatr       Date:  2022-02-11       Impact factor: 3.418

8.  Epigenetic hypomethylation and upregulation of matrix metalloproteinase 9 in Kawasaki disease.

Authors:  Ho-Chang Kuo; Sung-Chou Li; Lien-Hung Huang; Ying-Hsien Huang
Journal:  Oncotarget       Date:  2017-07-28

9.  Serum Levels of Syndecan-1 in Patients With Kawasaki Disease.

Authors:  Li Luo; Siqi Feng; Yao Wu; Ya Su; Fengchuan Jing; Qijian Yi
Journal:  Pediatr Infect Dis J       Date:  2019-01       Impact factor: 2.129

10.  Identification of Key Genes and Underlying Mechanisms in Acute Kawasaki Disease Based on Bioinformatics Analysis.

Authors:  Side Gao; Wenjian Ma; Xuze Lin; Sizhuang Huang; Mengyue Yu
Journal:  Med Sci Monit       Date:  2021-07-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.